Impact of Metformin on Cancer Biomarkers in Non-Diabetic Cancer Patients: A Systematic Review and Meta-Analysis of Clinical Trials
Introduction: Our aim was to investigate and evaluate the influence of metformin on cancer-related biomarkers in clinical trials. Methods: This systematic study was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. Major databases, includi...
Main Authors: | Tahereh Farkhondeh, Alireza Amirabadizadeh, Hamed Aramjoo, Silvia Llorens, Babak Roshanravan, Farhad Saeedi, Marjan Talebi, Mehdi Shakibaei, Saeed Samarghandian |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Current Oncology |
Subjects: | |
Online Access: | https://www.mdpi.com/1718-7729/28/2/134 |
Similar Items
-
Application value of Ki67 and serum CA125 in the deep myometrial invasion of endometrial adenocarcinoma
by: Lin Qin
Published: (2023-03-01) -
Exploring the Prognostic and Predictive Roles of Ki-67 in Endometrial Cancer
by: Laura Paleari, et al.
Published: (2023-11-01) -
Changes in the expression of cancer- and metastasis-related genes and proteins after metformin treatment under different metabolic conditions in endometrial cancer cells
by: Carsten Lange, et al.
Published: (2023-06-01) -
Relationship Between SUVmax and Ki-67 Expression in Breast Cancer
by: Meriç Emre Bostancı, et al.
Published: (2020-09-01) -
Prognosis of breast cancer patients and survival rate related with Ki-67 proliferation index: multicenter retrospective study
by: Sanjay D. Dandona
Published: (2021-12-01)